Meeting the immense need for HAART in resource-poor settings

Affiliations

Review

Johannes A Bogaards et al. J Antimicrob Chemother. 2003 Nov.

. 2003 Nov;52(5):743-6.

doi: 10.1093/jac/dkg454. Epub 2003 Oct 16.

¹ Departments of Human Retrovirology, Clinical Epidemiology and Biostatistics, University of Amsterdam, Amsterdam, The Netherlands. j.a.bogaards@amc.uva.nl

No abstract available

Similar articles

Suitable monitoring approaches to antiretroviral therapy in resource-poor settings: setting the research agenda.
Kent DM, McGrath D, Ioannidis JP, Bennish ML. Kent DM, et al. Clin Infect Dis. 2003 Jul 1;37(Suppl 1):S13-24. doi: 10.1086/375368. Clin Infect Dis. 2003. PMID: 12822128
Highly active antiretroviral therapy (HAART)--plus: next steps to enhance HAART in resource-limited areas?
Flanigan TP, Wools-Kaloustain K, Harwell J, Cu-Uvin S, Kimaiyo S, Carter EJ. Flanigan TP, et al. Clin Infect Dis. 2007 Dec 1;45(11):1499-501. doi: 10.1086/522992. Epub 2007 Oct 22. Clin Infect Dis. 2007. PMID: 17990234 No abstract available.
The use of total lymphocyte count (TLC) as an independent criterion for initiating HAART in resource-poor countries.
Lee SS, Wong KH. Lee SS, et al. J Infect. 2005 Jan;50(1):66-7. doi: 10.1016/j.jinf.2003.11.011. J Infect. 2005. PMID: 15603843
Management of Kaposi's sarcoma in resource-limited settings in the era of HAART.
Lynen L, Zolfo M, Huyst V, Louis F, Barnardt P, Van de Velde A, De Schacht C, Colebunders R. Lynen L, et al. AIDS Rev. 2005 Jan-Mar;7(1):13-21. AIDS Rev. 2005. PMID: 15875657 Review.
Antiretroviral treatment in resource-poor settings: public health research priorities.
Jaffar S, Govender T, Garrib A, Welz T, Grosskurth H, Smith PG, Whittle H, Bennish ML. Jaffar S, et al. Trop Med Int Health. 2005 Apr;10(4):295-9. doi: 10.1111/j.1365-3156.2005.01390.x. Trop Med Int Health. 2005. PMID: 15807791 Review.